Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 15/20 | 0.47 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14580673 | 1.00 | PDK2 (0.47) | PDK2CLK4DYRK1AADRB2KDM4E | |
| SCHEMBL9920507 | 1.00 | PDK2 (0.47) | PDK2CLK4DYRK1AADRB2KDM4E | |
| SCHEMBL12390430 | 0.93 | PDK2 (0.41) | PDK2CLK4DYRK1AADRB2 | |
| SCHEMBL14731178 | 0.92 | PDK2 (0.43) | PDK2 | |
| SCHEMBL12390417 | 0.90 | PDK2 (0.43) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL19383442 | 0.88 | PDK2 (0.46) | PDK2MEN1LMNAMAPTKMT2A | |
| SCHEMBL15977790 | 0.87 | PDK2 (0.39) | PDK2 | |
| SCHEMBL14580672 | 0.87 | KMT2A (0.43) | PDK2KDM4EMEN1MAPTKMT2A | |
| SCHEMBL29603105 | 0.86 | PDK2 (0.39) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL14580681 | 0.86 | PDK2 (0.39) | PDK2KDM4EMEN1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362246-B2 | Bispyrimidines for electronic applications | BASF SE (DE) | 2013-01-29 | — | — | US | disclosed |
| US-8362246-B2 | Bispyrimidines for electronic applications | BASF SE (DE) | 2013-01-29 | — | — | US | disclosed |
| WO-2012080052-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-06-21 | — | — | WO | disclosed |
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-06-14 | — | — | US | disclosed |
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-06-14 | — | — | US | disclosed |
| US-8003227-B2 | Organic electroluminescent element | MERCK PATENT GMBH (DE) | 2011-08-23 | — | — | US | disclosed |
| US-8003227-B2 | Organic electroluminescent element | MERCK PATENT GMBH (DE) | 2011-08-23 | — | — | US | disclosed |
| US-20070051944-A1 | Organic electroluminescent element | MERCK PATENT GMBH (DE) | 2007-03-08 | — | — | US | disclosed |
| US-20070051944-A1 | Organic electroluminescent element | MERCK PATENT GMBH (DE) | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | DPYD, TYMP, TYMS | PDK2 104/4885CLK4 3929/4885DYRK1A 3240/4885 |
| US-20070051944-A1 | Organic electroluminescent element | POU5F1, POU2F1, LEF1 | PDK2 448/4885CLK4 3734/4885DYRK1A 4315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.